SlideShare a Scribd company logo
1 of 70
Download to read offline
Relapse:
Road to Recovery
Dr. Jay Piland MD
Palmetto Addiction Recovery Center
Pecan Haven Adolescent Addiction Center
Spectrum of Substance Use Disorders
Misuse
20% 65% ?%
Regular
Use
Zero
use Mild
Moderate
Severe
“Pickle Line”
adapted from Ray Baker MD
Healthy No Problem
Use Related
Problem
Substance Use
Disorders
Road to Recovery
DSM 5 Diagnostic Criteria
11 Criteria in 4 groupings (2-3=mild, 4-5=moderate, 6+=severe)
Impaired Control
Inability to quit or cut down, using more than intended, time spent, craving
Social (Functional) Impairment
School, Work, Home Obligations Not Met
Social and Relationship Problems
Social, Occupational, Recreational Activities Abandoned
Risky Use (Using Despite)
Hazardous Situations
Physical or Mental Illness/Psychological Problems
Pharmacological (Physiological)
Tolerance and Withdrawal
Road to Recovery
“Sometimes it’s not so much seeing the
light as feeling the heat.”
Road to Recovery
Barriers for HCP’s seeking and
receiving assistance
Road to Recovery
• 2/3 of pharmacists in recovery treatment programs
are discovered by their state board of pharmacy, a
peer, or another HCP
• Some discovered by law enforcement caught abusing a
substance or engaging in a related illegal activity
• Many may actually believe their own knowledge of
medications will somehow prevent them from
becoming addicted or dependent
• Many studies show that HCP’s may believe their
knowledge of drug therapy justifies self-treatment
Road to Recovery
The Addicted Pharmacist and the Effect of Their Environment
University of Findlay College of Pharmacy
PRN Survey (N 171—25%)
• From Discovery to Recovery
• 93% attended Some form of Rehabilitation
– Of which 63% Successful on First Attempt
– Of which 18% Successful on Second Attempt
– Of which 11% Successful on Third Attempt
Road to Recovery
CDM: Performance Measures
Help Guide Care
Road to Recovery
“Blueprint” Study
McLellan et.al., BMJ, Nov. 2008
• 16 American PHPs retrospective longitudinal study
• 904 consecutive MDs with SUDs, 647 monitored
• 81% never relapsed over five years
• 79% licensed and working after five years
• 11% revoked
• 3.5% retired
• 3.5% died
• 3% status unknown
Road to Recovery
Relapse Risk (Washington State PHP)
(Domino, et. al. JAMA, Mar 23, 2005)
Retrospective Cohort Study
• Relapse rate: 25% (74 of 292 cases between 1991-
2001)
• Increased relapse risk if:– Concurrent psychiatric disorder (HR 5.79)
– Family history of substance use disorder (HR 2.29)
– Previous major relapse (HR 1.69)
– Combinations of these adds to cumulative risk
– Major Opioid/Dual Diagnosis/Family History (HR 13.25)
• No increased relapse risk:
– Drug of choice
• Including major opioid as long as above factors absent
– Specialty
– Gender
Road to Recovery
OMA PHP Relapses - 5 Year Program
First 100 monitored participants
Brewster, Kaufmann et al; BMJ Nov 2008
Road to Recovery
LIFE SATISFACTION* BY
PROGRAM YEAR - OMA PHP
YEAR IN PROGRAM
* Mean of 14-items: 4-Very satisfied; 3-Satisfied; 2-Dissatisfied; 1-Very dissatisfied
R2 = .813; Regression constant = 3.266; Slope = 0.0498 (p = .037)
Road to Recovery
PFSP Program Evaluation 2008: Did PFSP
make a difference for participants in case
coordination?
90% of responding participants reported that the problem that
had caused them to access the program had improved (46%
responded)
• Overall wellness
• Job effectiveness
• Relationships with
others
full 76% partial 14%
full 71% partial 14%
full 71% partial 24%
Overall life satisfaction
• Beginning of case coordination3.7/10
• Conclusion of last interaction 8.1/10
Road to Recovery
Special Issues of Return to Work
• PHP/PRNs usually spell out the conditions for
a HCP’s return to practice via a contract.
• Most Regulator’s specify only that the HCP
return to work should be based on her/his
ability to practice with “reasonable skill and
safety”—leaving judgement up to treatment
team
Road to Recovery
Special Issues of Return to Work
• Assessment of her/his:
– Acceptance of SUD diagnosis
– Understanding of addiction as a chronic disease requiring lifelong attention
– Completion of SUD treatment, with support of treatment team to resume
work
– Documentation of sustained abstinence(UDS).
– Treatment and status of Co-occurring Mental Disorders
– Judgment and cognition (neuropsychological testing)
– HCP’s ability to manage stress and triggers
– Support Network including Family support
– Estimated risk of Relapse
– Motivation to follow an established continuing care plan
– Occupational Factors:
• Legal/Licensure Requirements Satisfied
• Workplace monitor/supervisor identified and accepts responsibilities
• Necessary Workplace modification or practice restrictions have been agreed to
Road to Recovery
Special Issues of Return to Work
• Staged Process
• May have limited work hours, tasks, time of day, or settings
• May face restrictions to access to mood-altering medications
• Workplace monitor in contact with PHP/PRN (release for communication
in effect at all times)
• Settings of practice limited to provide for easier monitoring/better
accountability
• Accountability System for dispensing/administering addicting drugs to
patients
– Not being the person in the practice to check a patient’s medications for
compliance
– Keeping track of prescriptions written for controlled substances
– Using double locked systems for addicting substances on premises
– Periodic checking of wastage from injectable opioids to assure all vials and
their contents are properly accounted for & have not been diverted
Road to Recovery
Applying Occupational Health
Principles
• Safety-Sensitive Profession
• Workplace education and accommodations are
often required
• Participate in return to work planning with the
participant and the workplace
• Fitness for work measured by performance on a
range of work tasks from low to higher risk
• Scrutiny and accountability in the workplace is
necessary
• Monitor long-term for Health and Recovery
Road to Recovery
Relapse:
Road to Recovery
Dr. Jay Piland MD
Palmetto Addiction Recovery Center
Pecan Haven Adolescent Addiction Center
Road to Recovery
Road to Recovery
Relapse:
• Definition varies according to source text.
• Addiction Medicine-Fourth Edition 2009:
• Uses terms Lapse, Relapse, and Recovery.
• Some argument over what constitutes a
Relapse-but not from PHP programs. Use a
higher standard of complete abstinence from
mood altering substances.
Road to Recovery
Lapse
• Marlatt defines as the initial episode of use of
a substance after a period of abstinence.
• Not really recognized for professionals.
Road to Recovery
Relapse:
• “ a discrete phenomenon or a process of
behavioral change”
• “an unfolding process in which the
resumption of substance use is the LAST
event in a long series of maladaptive
responses to internal or external stressors or
stimuli”
• “ a continuous process defined by a series of
transgressive behaviors”
Road to Recovery
Road to Recovery
Road to Recovery
Interventions Do Work
Behavior Patterns
• It’s the behavior stupid.
• Mechanism of response to stressors and
stimuli—I.E.—LIFE.
• Response can be healthy or maladaptive
Road to Recovery
Recovery
• Recovery is defined as a long-term and
ongoing process rather than an endpoint.
• Specific areas of change during the process of
recovery include physical, psychologic,
spiritual, behavioral, interpersonal,
sociocultural, familial, and financial.
• Recovery tasks and areas of clinical focus are
contingent on the phase of recovery .
Road to Recovery
Stages of Relapse:
• Used by PHP and RNP programs nationwide.
• 3 stages of relapse.
• Evidence shows progression over time.
• Measurement of severity of relapse but not
necessarily indicative of recommended
corrective actions from monitoring programs.
Road to Recovery
Level 1 Relapse
• A level 1 relapse consists of missing therapy
meetings, support groups, dishonesty, or
other behavioral infractions.
• Note-no mention of substances.
Road to Recovery
Level 2 Relapse
• A level 2 relapse involves the reuse of drugs or
alcohol but outside the context of medical
practice.
• Not necessarily a person’s drug of choice.
Road to Recovery
Level 3 Relapse
• Involves the use of drugs or alcohol within the
context of medical practice.
• Main goal of PHP programs is to prevent this
occurence.
• PHP’s, PRN’s, and RNP’s primary directive:
Protect the Public.
Road to Recovery
Consequences
• Different for professionals than the general
public because we present a greater danger
than just to ourselves.
• “Physicians who have difficulty maintaining
abstinence should be removed from the
workforce until treatment providers….feel that
the physician is safe to return to work.”
Road to Recovery
Consequences 2
• “ The point in time when a physician is safe to
practice is best determined by a joint decision
of the physician’s treatment provider and the
monitoring PHP.”
Road to Recovery
Determinants of Relapse
• Marlatt’s Relapse Taxonomy:
• Intrapersonal Determinants
– Self Efficacy
– Outcome Expectancies
– Cravings
– Motivation
– Coping
– Emotional States
• Interpersonal Determinants
Road to Recovery
Intrapersonal Determinants
• Self-efficacy: refers to the individuals beliefs in
their capabilities to organize and carry out
specific courses of action to attain some goal
or situation specific task.
• This construct is intimately related to the
individual’s coping abilities.
• The patient’s personal belief in his or her
ability to control substance use is a reliable
predictor of relapse.
Road to Recovery
Self-Efficacy
• If you believe you can you will.
• Confidence in your ability to control your
substance use is intimately related with your
coping skills.
• Coping behaviors should be thoroughly
assessed during treatment and appropriately
targeted for interventions.
Road to Recovery
Road to Recovery
Outcome Expectancy
• A factor enhancing the likelihood of relapse is
the set of cognitive expectancies that
individuals develop regarding the expected
outcomes of substance use.
• If it feels good do it. Not a good plan.
• Treatment should focus to some extent on
changing the individual’s outcome
expectancies regarding substance use.
Road to Recovery
Road to Recovery
Craving
• Defined as a cognitive experience focused on
the desire to use a substance.
• Closely related to outcome expectancies.
• Different from behavioral urges.
• Treatment should also include an evaluation
of cravings and appropriate readjustment
based on outcome expectancies.
Road to Recovery
Road to Recovery
Motivation
• Gorski: The degree to which a person’s
behavior differs from their ideal behavior
beliefs is the degree of that person’s insanity.
• The person’s desire for self improvement and
commitment to change is a strong predictor
of relapse.
• Ambivalence toward change is the enemy of
recovery.
Road to Recovery
Road to Recovery
Coping
• “Based upon cognitive-behavioral model of
relapse, the most critical predictor of relapse
is the individuals ability to utilize adequate
coping strategies in dealing with high-risk
situations.”
• One of the most effective coping strategies
available is mindfulness and meditation.
• Foundation of behavioral change.
Road to Recovery
Road to Recovery
Road to Recovery
Emotional States
• Studies show a strong link between negative
affect and relapse to substance abuse.
• It is the cornerstone of effective recovery;
affect is a strong determinant of subsequent
behavior.
• Two things you can control: Attitude and
Behavior. They are intimately associated.
Road to Recovery
Road to Recovery
Interpersonal Determinants
• Functional support or the level of emotional
support is highly predictive of long term
abstinence and recovery.
• Behavioral therapy which incorporates
partner support in treatment goals is one of
the top three empirically supported
treatment methods for alcohol problems.
• Al-Anon is born.
Road to Recovery
Road to Recovery
Top 10 ways to Prevent Relapse
• 1) Help patients understand relapse as a
process and event, and learn to identify
warning signs.
Road to Recovery
RP
• 2) Help patients identify their high risk
situations and develop effective cognitive and
behavioral coping.
Road to Recovery
RP
• 3) Help patients enhance their communication
skills, interpersonal relationships, and develop
a recovery social network.
Road to Recovery
RP
• 4) Help patients reduce, identify, and manage
negative emotional states.
Road to Recovery
RP
• 5) Help patients identify and manage cravings
and cues that precede cravings.
Road to Recovery
RP
• 6) Help patients identify and challenge
cognitive distortions.
Road to Recovery
Road to Recovery
RP
• 7) Help patients work toward a more balanced
lifestyle.
Road to Recovery
RP
• 8) Consider the use of medications in
combination with psychosocial treatments.
Road to Recovery
RP
• 9) Facilitate the transition between levels of
care for patients completing residential or
hospital based inpatient treatment programs,
or structured partial hospital or intensive
outpatient programs.
• PRN’s PHP’s RNP’s CM
Road to Recovery
RP
• 10) Incorporate strategies to improve
adherence to treatment and medication.
Road to Recovery
Susan P. Rx Relapse ?
• Susan is a 35 year old Pharmacist who was treated for alcohol SUD
at the age of 24. After treatment she enrolled in the PRN
monitoring and signed a 5 year monitoring contract.
• After the completion of her five year contract at the age of 29 she
had been very engaged in her peer support recovery program (AA,
Caduceus, Continuing Care, and UDS monitoring) but stopped
going about six months before the end of her contract.
• Three months prior to completion of her contract, Susan
discovered she was pregnant—she had noticed a significant mood
change(depression) and an increase in her anxiety level due to
difficulty with her supervisor at work (Hospital Pharmacy). She also
was increasingly anxious due to her infidelities which occurred with
another coworker who was a 22 year old pharmacy student—which
she ended at 8 months into her pregnancy—after being involved
with him for several months.
Road to Recovery
Susan P Rx Relapse ?
• Is Susan P. in Relapse?
• Would she benefit from being in a social recovery
Network?
• How could she be better managing her “negative
emotional state”?
• What emotions are driving that “state”?
Road to Recovery
Susan P Rx Relapse?
• She had a child (son) who was born about six months after
completing her monitoring contract(out of meetings for about 1
year. She did have to undergo a C-section and the birth was
complicated with some fetal distress prior to delivery—yet no
anomalies were noted in the infant. Susan received a Rx for
Percocet 10mg after the C-section and took three refills. (when
taking the Percocet—she began to think about a repeated dose
within 1 hour of last dose and could not get it off her mind)
• Susan returned to work after only 8 weeks at home after the C-
section. She had stopped having contact with her sponsor as she
was no longing attending AA meetings (not enough time). Also her
sponsor had advised her to end the previous relationship after
Susan had only one sexual encounter with him at age 33—she did
not follow the suggestions—the relationship continued for several
months. She had been working with a girl in early recovery but
stopped working with her after stopping the meetings.
Road to Recovery
Susan P. Rx Relapse
• Is Susan in Relapse?
• What Level?
• What did she not do with her
pregnancy/delivery?
• What could Susan have done with Cravings?
Road to Recovery
Susan P Rx Relapse ?
• Susan returned to her habit of smoking cigarettes (she had stopped at age
24) only two weeks after her son was born. Susan also began to
experience recurring episodes of dysphoria within that same time frame,
she also experienced recurring “flash-backs” of early childhood sexual
trauma she experienced at the age of 8 by an “uncle”. She would have
recurrent thoughts of being worthless and not being able to do anything
right—she began to think that her tendency to “gamble” was the reason
for sexual trauma “flash-backs”.
• She was responsible for filling the Pyxis machines with all of the narcotics
when she returned to work from maternity leave—so she progressively
increased her use up to 25 Percocet tablets daily. She took “50 Percocet
capsules” in a “suicide attempt” when her supervisor began to perform
internal Pyxis pharmacy audits. She now presents for an addiction
assessment after getting out of the acute care hospital.
•
Road to Recovery
Susan P Rx Relapse?
• 15. Does Cigarette Smoking increase her risk
of relapse?
• 16. What should she do about “flash-backs”?
• 17. What should she do about cognitive
distortions?
• 18. Should she be on MAT? Vivitrol?
• 19. What is most appropriate next step?
Road to Recovery
Susan P. Rx Relapse?
True/False?
21. Relapse Prevention plans should always be started at the
middle/end of treatment.
22. Performing a relapse autopsy is always useful.
23. Most HCP’s who relapse, always loose their license and ability to
practice their profession.
24. Many HCP’s who have an early relapse, often are able to achieve
and improved footing/foundation of a recovery program.
25. IDAA. Look us up www.ida.org
Road to Recovery
Relapse:
Road to Recovery
Dr. Jay Piland MD
Palmetto Addiction Recovery Center
Pecan Haven Adolescent Addiction Center

More Related Content

What's hot

CBT as a core of psychotherapy in relapse prevention of addiction
CBT as a core of psychotherapy in relapse prevention of addictionCBT as a core of psychotherapy in relapse prevention of addiction
CBT as a core of psychotherapy in relapse prevention of addictionRaghda Gamil
 
Week 6 emotion and addiction with hand out
Week 6 emotion and addiction with hand outWeek 6 emotion and addiction with hand out
Week 6 emotion and addiction with hand outAriel. Christopher, BSW
 
Dbt substance abuse presentation
Dbt substance abuse presentationDbt substance abuse presentation
Dbt substance abuse presentationaliciaelawson
 
Relapse Prevention Strategies.pptx
Relapse Prevention  Strategies.pptxRelapse Prevention  Strategies.pptx
Relapse Prevention Strategies.pptxAkankshaRaniPsycholo
 
Addiction
AddictionAddiction
Addictionjben501
 
EMDR Powerpoint Presentation
EMDR Powerpoint PresentationEMDR Powerpoint Presentation
EMDR Powerpoint Presentationmccmarc
 
Cognitive Therapy for Addiction
Cognitive Therapy for Addiction Cognitive Therapy for Addiction
Cognitive Therapy for Addiction drfrankryan
 
Substance Abuse and Mental Health Disorders
Substance Abuse and Mental Health DisordersSubstance Abuse and Mental Health Disorders
Substance Abuse and Mental Health DisordersAngela Penny, MBA
 
An Introduction to SMART Recovery
An Introduction to SMART RecoveryAn Introduction to SMART Recovery
An Introduction to SMART RecoverySMARTRecovery
 

What's hot (20)

Relapse Prevention
Relapse PreventionRelapse Prevention
Relapse Prevention
 
CBT as a core of psychotherapy in relapse prevention of addiction
CBT as a core of psychotherapy in relapse prevention of addictionCBT as a core of psychotherapy in relapse prevention of addiction
CBT as a core of psychotherapy in relapse prevention of addiction
 
Week 6 emotion and addiction with hand out
Week 6 emotion and addiction with hand outWeek 6 emotion and addiction with hand out
Week 6 emotion and addiction with hand out
 
Dbt substance abuse presentation
Dbt substance abuse presentationDbt substance abuse presentation
Dbt substance abuse presentation
 
Addiction
AddictionAddiction
Addiction
 
Relapse prevention
Relapse preventionRelapse prevention
Relapse prevention
 
Relapse prevention 2 2 hours
Relapse prevention 2 2 hoursRelapse prevention 2 2 hours
Relapse prevention 2 2 hours
 
Triggers and Cravings - Live Webinar
Triggers and Cravings - Live WebinarTriggers and Cravings - Live Webinar
Triggers and Cravings - Live Webinar
 
Relapse Prevention Strategies.pptx
Relapse Prevention  Strategies.pptxRelapse Prevention  Strategies.pptx
Relapse Prevention Strategies.pptx
 
Addiction
AddictionAddiction
Addiction
 
Behavioural Addictions and Suicide
Behavioural Addictions and SuicideBehavioural Addictions and Suicide
Behavioural Addictions and Suicide
 
EMDR Powerpoint Presentation
EMDR Powerpoint PresentationEMDR Powerpoint Presentation
EMDR Powerpoint Presentation
 
Cognitive Therapy for Addiction
Cognitive Therapy for Addiction Cognitive Therapy for Addiction
Cognitive Therapy for Addiction
 
Distress Tolerance Skills and Activities
Distress Tolerance Skills and ActivitiesDistress Tolerance Skills and Activities
Distress Tolerance Skills and Activities
 
Co-Dependency Awareness and Interventions
Co-Dependency Awareness and InterventionsCo-Dependency Awareness and Interventions
Co-Dependency Awareness and Interventions
 
Behavioral Addictions: Identification and Treatment
Behavioral Addictions: Identification and TreatmentBehavioral Addictions: Identification and Treatment
Behavioral Addictions: Identification and Treatment
 
Substance Abuse and Mental Health Disorders
Substance Abuse and Mental Health DisordersSubstance Abuse and Mental Health Disorders
Substance Abuse and Mental Health Disorders
 
An Introduction to SMART Recovery
An Introduction to SMART RecoveryAn Introduction to SMART Recovery
An Introduction to SMART Recovery
 
Drugs of Abuse: Addiction Theory
Drugs of Abuse: Addiction TheoryDrugs of Abuse: Addiction Theory
Drugs of Abuse: Addiction Theory
 
Theories of Addiction
Theories of AddictionTheories of Addiction
Theories of Addiction
 

Viewers also liked

Grief & mourning workshop 01 20 09
Grief & mourning workshop 01 20 09Grief & mourning workshop 01 20 09
Grief & mourning workshop 01 20 09ICCarpenter
 
Grief and Loss in Addiction and Recovery - September 2012
Grief and Loss in Addiction and Recovery - September 2012Grief and Loss in Addiction and Recovery - September 2012
Grief and Loss in Addiction and Recovery - September 2012Dawn Farm
 
The Seven Steps To Building A Successful Prevention Program
The Seven Steps To Building A Successful Prevention ProgramThe Seven Steps To Building A Successful Prevention Program
The Seven Steps To Building A Successful Prevention ProgramUniversity of New Mexico
 
Behavior Change Determinants
Behavior Change DeterminantsBehavior Change Determinants
Behavior Change DeterminantsAan Erlian
 
socrratic dialouge
socrratic dialougesocrratic dialouge
socrratic dialougeehab elbaz
 
Drug & substance abuse Marijuana, Cocaine, Heroine, alcohol and prescription...
Drug  & substance abuse Marijuana, Cocaine, Heroine, alcohol and prescription...Drug  & substance abuse Marijuana, Cocaine, Heroine, alcohol and prescription...
Drug & substance abuse Marijuana, Cocaine, Heroine, alcohol and prescription...OrnellaRN
 

Viewers also liked (8)

Grief & mourning workshop 01 20 09
Grief & mourning workshop 01 20 09Grief & mourning workshop 01 20 09
Grief & mourning workshop 01 20 09
 
Presentation
Presentation Presentation
Presentation
 
Grief & loss.drjma
Grief & loss.drjmaGrief & loss.drjma
Grief & loss.drjma
 
Grief and Loss in Addiction and Recovery - September 2012
Grief and Loss in Addiction and Recovery - September 2012Grief and Loss in Addiction and Recovery - September 2012
Grief and Loss in Addiction and Recovery - September 2012
 
The Seven Steps To Building A Successful Prevention Program
The Seven Steps To Building A Successful Prevention ProgramThe Seven Steps To Building A Successful Prevention Program
The Seven Steps To Building A Successful Prevention Program
 
Behavior Change Determinants
Behavior Change DeterminantsBehavior Change Determinants
Behavior Change Determinants
 
socrratic dialouge
socrratic dialougesocrratic dialouge
socrratic dialouge
 
Drug & substance abuse Marijuana, Cocaine, Heroine, alcohol and prescription...
Drug  & substance abuse Marijuana, Cocaine, Heroine, alcohol and prescription...Drug  & substance abuse Marijuana, Cocaine, Heroine, alcohol and prescription...
Drug & substance abuse Marijuana, Cocaine, Heroine, alcohol and prescription...
 

Similar to Relapse Prevention

Successful endeavors and_outcomes_final
Successful endeavors and_outcomes_finalSuccessful endeavors and_outcomes_final
Successful endeavors and_outcomes_finalOPUNITE
 
Addiction-and-the-Brain-Inova-Template_-002(1).pptx
Addiction-and-the-Brain-Inova-Template_-002(1).pptxAddiction-and-the-Brain-Inova-Template_-002(1).pptx
Addiction-and-the-Brain-Inova-Template_-002(1).pptxmograine
 
Addiction treatment models mammoura final
Addiction treatment models mammoura finalAddiction treatment models mammoura final
Addiction treatment models mammoura finalMPH_training_committee
 
RXP International Presents an Overview of Prescribing Psychologists
RXP International Presents an Overview of Prescribing PsychologistsRXP International Presents an Overview of Prescribing Psychologists
RXP International Presents an Overview of Prescribing PsychologistsRXP International
 
Rx15 clinical wed_1230_1_moskowitz_2hall
Rx15 clinical wed_1230_1_moskowitz_2hallRx15 clinical wed_1230_1_moskowitz_2hall
Rx15 clinical wed_1230_1_moskowitz_2hallOPUNITE
 
Generalist Practice A Presentation on Steps of The Problem-Solv
Generalist Practice A Presentation on Steps of The Problem-SolvGeneralist Practice A Presentation on Steps of The Problem-Solv
Generalist Practice A Presentation on Steps of The Problem-SolvMatthewTennant613
 
Treatment opioids a_comprehensive_response_final
Treatment opioids a_comprehensive_response_finalTreatment opioids a_comprehensive_response_final
Treatment opioids a_comprehensive_response_finalOPUNITE
 
Rx16 advocacy tues_330_1_olsen_2raymond_3conover
Rx16 advocacy tues_330_1_olsen_2raymond_3conoverRx16 advocacy tues_330_1_olsen_2raymond_3conover
Rx16 advocacy tues_330_1_olsen_2raymond_3conoverOPUNITE
 
Rx15 treat wed_1230_1_gitlow_2gastfriend
Rx15 treat wed_1230_1_gitlow_2gastfriendRx15 treat wed_1230_1_gitlow_2gastfriend
Rx15 treat wed_1230_1_gitlow_2gastfriendOPUNITE
 
Relapse Prevention Counseling Strategies for SUD Clients
Relapse Prevention Counseling Strategies for SUD ClientsRelapse Prevention Counseling Strategies for SUD Clients
Relapse Prevention Counseling Strategies for SUD ClientsAaron Garner
 
Principles of De addiction Programme
Principles of De addiction ProgrammePrinciples of De addiction Programme
Principles of De addiction ProgrammeMayur Chaudhari
 
Characteristics and Outcomes of Adult Opiate Users in Abstinence-Based Resid...
Characteristics and Outcomes of Adult Opiate Users in Abstinence-Based  Resid...Characteristics and Outcomes of Adult Opiate Users in Abstinence-Based  Resid...
Characteristics and Outcomes of Adult Opiate Users in Abstinence-Based Resid...Siobhan Morse
 
Psychological dimensions
Psychological dimensionsPsychological dimensions
Psychological dimensionscaяen iz lovǝ
 
Schizophrenia management
Schizophrenia management Schizophrenia management
Schizophrenia management Pavan kulkarni
 
Rx15 clinical tues_1115_1_porathwaller-robeson_2fan-lewis-noonan
Rx15 clinical tues_1115_1_porathwaller-robeson_2fan-lewis-noonanRx15 clinical tues_1115_1_porathwaller-robeson_2fan-lewis-noonan
Rx15 clinical tues_1115_1_porathwaller-robeson_2fan-lewis-noonanOPUNITE
 

Similar to Relapse Prevention (20)

Relapse Recovery in Pharmacists
Relapse Recovery in PharmacistsRelapse Recovery in Pharmacists
Relapse Recovery in Pharmacists
 
Slide show 3.15.17
Slide show 3.15.17Slide show 3.15.17
Slide show 3.15.17
 
Successful endeavors and_outcomes_final
Successful endeavors and_outcomes_finalSuccessful endeavors and_outcomes_final
Successful endeavors and_outcomes_final
 
Addiction-and-the-Brain-Inova-Template_-002(1).pptx
Addiction-and-the-Brain-Inova-Template_-002(1).pptxAddiction-and-the-Brain-Inova-Template_-002(1).pptx
Addiction-and-the-Brain-Inova-Template_-002(1).pptx
 
Addiction treatment models mammoura final
Addiction treatment models mammoura finalAddiction treatment models mammoura final
Addiction treatment models mammoura final
 
Edema tx
Edema txEdema tx
Edema tx
 
RXP International Presents an Overview of Prescribing Psychologists
RXP International Presents an Overview of Prescribing PsychologistsRXP International Presents an Overview of Prescribing Psychologists
RXP International Presents an Overview of Prescribing Psychologists
 
Opioid Use
Opioid Use Opioid Use
Opioid Use
 
Rx15 clinical wed_1230_1_moskowitz_2hall
Rx15 clinical wed_1230_1_moskowitz_2hallRx15 clinical wed_1230_1_moskowitz_2hall
Rx15 clinical wed_1230_1_moskowitz_2hall
 
Generalist Practice A Presentation on Steps of The Problem-Solv
Generalist Practice A Presentation on Steps of The Problem-SolvGeneralist Practice A Presentation on Steps of The Problem-Solv
Generalist Practice A Presentation on Steps of The Problem-Solv
 
Treatment opioids a_comprehensive_response_final
Treatment opioids a_comprehensive_response_finalTreatment opioids a_comprehensive_response_final
Treatment opioids a_comprehensive_response_final
 
Rx16 advocacy tues_330_1_olsen_2raymond_3conover
Rx16 advocacy tues_330_1_olsen_2raymond_3conoverRx16 advocacy tues_330_1_olsen_2raymond_3conover
Rx16 advocacy tues_330_1_olsen_2raymond_3conover
 
Rx15 treat wed_1230_1_gitlow_2gastfriend
Rx15 treat wed_1230_1_gitlow_2gastfriendRx15 treat wed_1230_1_gitlow_2gastfriend
Rx15 treat wed_1230_1_gitlow_2gastfriend
 
Relapse Prevention Counseling Strategies for SUD Clients
Relapse Prevention Counseling Strategies for SUD ClientsRelapse Prevention Counseling Strategies for SUD Clients
Relapse Prevention Counseling Strategies for SUD Clients
 
Principles of De addiction Programme
Principles of De addiction ProgrammePrinciples of De addiction Programme
Principles of De addiction Programme
 
Characteristics and Outcomes of Adult Opiate Users in Abstinence-Based Resid...
Characteristics and Outcomes of Adult Opiate Users in Abstinence-Based  Resid...Characteristics and Outcomes of Adult Opiate Users in Abstinence-Based  Resid...
Characteristics and Outcomes of Adult Opiate Users in Abstinence-Based Resid...
 
alcohol use disorder.pptx
alcohol use disorder.pptxalcohol use disorder.pptx
alcohol use disorder.pptx
 
Psychological dimensions
Psychological dimensionsPsychological dimensions
Psychological dimensions
 
Schizophrenia management
Schizophrenia management Schizophrenia management
Schizophrenia management
 
Rx15 clinical tues_1115_1_porathwaller-robeson_2fan-lewis-noonan
Rx15 clinical tues_1115_1_porathwaller-robeson_2fan-lewis-noonanRx15 clinical tues_1115_1_porathwaller-robeson_2fan-lewis-noonan
Rx15 clinical tues_1115_1_porathwaller-robeson_2fan-lewis-noonan
 

Recently uploaded

person with disability and pwd act ppt.pptx
person with disability and pwd act ppt.pptxperson with disability and pwd act ppt.pptx
person with disability and pwd act ppt.pptxMUKESH PADMANABHAN
 
Basics of Giant Cell Tumor of bone (GCTB)
Basics of Giant Cell Tumor of bone (GCTB)Basics of Giant Cell Tumor of bone (GCTB)
Basics of Giant Cell Tumor of bone (GCTB)bishwabandhuniraula
 
2024 Compliatric Webianr Series - Contracts and MOUs from a HRSA Perspective.pdf
2024 Compliatric Webianr Series - Contracts and MOUs from a HRSA Perspective.pdf2024 Compliatric Webianr Series - Contracts and MOUs from a HRSA Perspective.pdf
2024 Compliatric Webianr Series - Contracts and MOUs from a HRSA Perspective.pdfCompliatric Where Compliance Happens
 
ACCA Version of AI & Healthcare: An Overview for the Curious
ACCA Version of AI & Healthcare: An Overview for the CuriousACCA Version of AI & Healthcare: An Overview for the Curious
ACCA Version of AI & Healthcare: An Overview for the CuriousKR_Barker
 
Artificial Intelligence in Healthcare: Challenges, Risks, Benefits
Artificial Intelligence in Healthcare: Challenges, Risks, BenefitsArtificial Intelligence in Healthcare: Challenges, Risks, Benefits
Artificial Intelligence in Healthcare: Challenges, Risks, BenefitsIris Thiele Isip-Tan
 
Three Keys to a Successful Margin: Charges, Costs, and Labor
Three Keys to a Successful Margin: Charges, Costs, and LaborThree Keys to a Successful Margin: Charges, Costs, and Labor
Three Keys to a Successful Margin: Charges, Costs, and LaborHealth Catalyst
 
Artificial Intelligence: Diabetes Management
Artificial Intelligence: Diabetes ManagementArtificial Intelligence: Diabetes Management
Artificial Intelligence: Diabetes ManagementIris Thiele Isip-Tan
 
NEONATAL RESPIRATORY CARE FROM A PHYSIO POV.pptx
NEONATAL RESPIRATORY CARE FROM A PHYSIO POV.pptxNEONATAL RESPIRATORY CARE FROM A PHYSIO POV.pptx
NEONATAL RESPIRATORY CARE FROM A PHYSIO POV.pptxHanineHassan2
 
Toothpaste for bleeding gums and sensitive teeth. Teeth whitening, Mouthwash....
Toothpaste for bleeding gums and sensitive teeth. Teeth whitening, Mouthwash....Toothpaste for bleeding gums and sensitive teeth. Teeth whitening, Mouthwash....
Toothpaste for bleeding gums and sensitive teeth. Teeth whitening, Mouthwash....sharyurangari111
 
Assisted Living Care Residency - PapayaCare
Assisted Living Care Residency - PapayaCareAssisted Living Care Residency - PapayaCare
Assisted Living Care Residency - PapayaCareratilalthakkar704
 
Identifying Signs of Mental Health Presentation (1).pptx
Identifying Signs of Mental Health Presentation (1).pptxIdentifying Signs of Mental Health Presentation (1).pptx
Identifying Signs of Mental Health Presentation (1).pptxsandhulove46637
 
Introduction to Evaluation and Skin Benefits
Introduction to Evaluation and Skin BenefitsIntroduction to Evaluation and Skin Benefits
Introduction to Evaluation and Skin Benefitssahilgabhane29
 
Health literacies in marginalised communities LILAC 24.pptx
Health literacies in marginalised communities LILAC 24.pptxHealth literacies in marginalised communities LILAC 24.pptx
Health literacies in marginalised communities LILAC 24.pptxPamela McKinney
 
ARTHRITIS.pptx Prepared by monika gopal Tutor
ARTHRITIS.pptx Prepared  by monika gopal TutorARTHRITIS.pptx Prepared  by monika gopal Tutor
ARTHRITIS.pptx Prepared by monika gopal TutorNehaKewat
 
LARYNGEAL CANCER.pptx Prepared by Neha Kewat
LARYNGEAL CANCER.pptx  Prepared by Neha KewatLARYNGEAL CANCER.pptx  Prepared by Neha Kewat
LARYNGEAL CANCER.pptx Prepared by Neha KewatNehaKewat
 
Hematinics and Erythropoietin- Pharmacology of Hematinics
Hematinics and Erythropoietin- Pharmacology of HematinicsHematinics and Erythropoietin- Pharmacology of Hematinics
Hematinics and Erythropoietin- Pharmacology of Hematinicsnetraangadi2
 
"ANATOMY AND PHYSIOLOGY OF THE SKIN".pdf
"ANATOMY AND PHYSIOLOGY OF THE SKIN".pdf"ANATOMY AND PHYSIOLOGY OF THE SKIN".pdf
"ANATOMY AND PHYSIOLOGY OF THE SKIN".pdfDolisha Warbi
 

Recently uploaded (20)

person with disability and pwd act ppt.pptx
person with disability and pwd act ppt.pptxperson with disability and pwd act ppt.pptx
person with disability and pwd act ppt.pptx
 
Basics of Giant Cell Tumor of bone (GCTB)
Basics of Giant Cell Tumor of bone (GCTB)Basics of Giant Cell Tumor of bone (GCTB)
Basics of Giant Cell Tumor of bone (GCTB)
 
The Power of Active listening - Tool in effective communication.pdf
The Power of Active listening - Tool in effective communication.pdfThe Power of Active listening - Tool in effective communication.pdf
The Power of Active listening - Tool in effective communication.pdf
 
2024 Compliatric Webianr Series - Contracts and MOUs from a HRSA Perspective.pdf
2024 Compliatric Webianr Series - Contracts and MOUs from a HRSA Perspective.pdf2024 Compliatric Webianr Series - Contracts and MOUs from a HRSA Perspective.pdf
2024 Compliatric Webianr Series - Contracts and MOUs from a HRSA Perspective.pdf
 
ACCA Version of AI & Healthcare: An Overview for the Curious
ACCA Version of AI & Healthcare: An Overview for the CuriousACCA Version of AI & Healthcare: An Overview for the Curious
ACCA Version of AI & Healthcare: An Overview for the Curious
 
Artificial Intelligence in Healthcare: Challenges, Risks, Benefits
Artificial Intelligence in Healthcare: Challenges, Risks, BenefitsArtificial Intelligence in Healthcare: Challenges, Risks, Benefits
Artificial Intelligence in Healthcare: Challenges, Risks, Benefits
 
Three Keys to a Successful Margin: Charges, Costs, and Labor
Three Keys to a Successful Margin: Charges, Costs, and LaborThree Keys to a Successful Margin: Charges, Costs, and Labor
Three Keys to a Successful Margin: Charges, Costs, and Labor
 
Artificial Intelligence: Diabetes Management
Artificial Intelligence: Diabetes ManagementArtificial Intelligence: Diabetes Management
Artificial Intelligence: Diabetes Management
 
Painting Rats White Angers Them to No End
Painting Rats White Angers Them to No EndPainting Rats White Angers Them to No End
Painting Rats White Angers Them to No End
 
NEONATAL RESPIRATORY CARE FROM A PHYSIO POV.pptx
NEONATAL RESPIRATORY CARE FROM A PHYSIO POV.pptxNEONATAL RESPIRATORY CARE FROM A PHYSIO POV.pptx
NEONATAL RESPIRATORY CARE FROM A PHYSIO POV.pptx
 
Toothpaste for bleeding gums and sensitive teeth. Teeth whitening, Mouthwash....
Toothpaste for bleeding gums and sensitive teeth. Teeth whitening, Mouthwash....Toothpaste for bleeding gums and sensitive teeth. Teeth whitening, Mouthwash....
Toothpaste for bleeding gums and sensitive teeth. Teeth whitening, Mouthwash....
 
Assisted Living Care Residency - PapayaCare
Assisted Living Care Residency - PapayaCareAssisted Living Care Residency - PapayaCare
Assisted Living Care Residency - PapayaCare
 
Identifying Signs of Mental Health Presentation (1).pptx
Identifying Signs of Mental Health Presentation (1).pptxIdentifying Signs of Mental Health Presentation (1).pptx
Identifying Signs of Mental Health Presentation (1).pptx
 
Introduction to Evaluation and Skin Benefits
Introduction to Evaluation and Skin BenefitsIntroduction to Evaluation and Skin Benefits
Introduction to Evaluation and Skin Benefits
 
Health literacies in marginalised communities LILAC 24.pptx
Health literacies in marginalised communities LILAC 24.pptxHealth literacies in marginalised communities LILAC 24.pptx
Health literacies in marginalised communities LILAC 24.pptx
 
ARTHRITIS.pptx Prepared by monika gopal Tutor
ARTHRITIS.pptx Prepared  by monika gopal TutorARTHRITIS.pptx Prepared  by monika gopal Tutor
ARTHRITIS.pptx Prepared by monika gopal Tutor
 
LARYNGEAL CANCER.pptx Prepared by Neha Kewat
LARYNGEAL CANCER.pptx  Prepared by Neha KewatLARYNGEAL CANCER.pptx  Prepared by Neha Kewat
LARYNGEAL CANCER.pptx Prepared by Neha Kewat
 
Hematinics and Erythropoietin- Pharmacology of Hematinics
Hematinics and Erythropoietin- Pharmacology of HematinicsHematinics and Erythropoietin- Pharmacology of Hematinics
Hematinics and Erythropoietin- Pharmacology of Hematinics
 
"ANATOMY AND PHYSIOLOGY OF THE SKIN".pdf
"ANATOMY AND PHYSIOLOGY OF THE SKIN".pdf"ANATOMY AND PHYSIOLOGY OF THE SKIN".pdf
"ANATOMY AND PHYSIOLOGY OF THE SKIN".pdf
 
SCOPE OF CRITICAL CARE ORGANIZATION
SCOPE OF CRITICAL CARE ORGANIZATIONSCOPE OF CRITICAL CARE ORGANIZATION
SCOPE OF CRITICAL CARE ORGANIZATION
 

Relapse Prevention

  • 1. Relapse: Road to Recovery Dr. Jay Piland MD Palmetto Addiction Recovery Center Pecan Haven Adolescent Addiction Center
  • 2. Spectrum of Substance Use Disorders Misuse 20% 65% ?% Regular Use Zero use Mild Moderate Severe “Pickle Line” adapted from Ray Baker MD Healthy No Problem Use Related Problem Substance Use Disorders Road to Recovery
  • 3. DSM 5 Diagnostic Criteria 11 Criteria in 4 groupings (2-3=mild, 4-5=moderate, 6+=severe) Impaired Control Inability to quit or cut down, using more than intended, time spent, craving Social (Functional) Impairment School, Work, Home Obligations Not Met Social and Relationship Problems Social, Occupational, Recreational Activities Abandoned Risky Use (Using Despite) Hazardous Situations Physical or Mental Illness/Psychological Problems Pharmacological (Physiological) Tolerance and Withdrawal Road to Recovery
  • 4. “Sometimes it’s not so much seeing the light as feeling the heat.” Road to Recovery
  • 5. Barriers for HCP’s seeking and receiving assistance Road to Recovery
  • 6. • 2/3 of pharmacists in recovery treatment programs are discovered by their state board of pharmacy, a peer, or another HCP • Some discovered by law enforcement caught abusing a substance or engaging in a related illegal activity • Many may actually believe their own knowledge of medications will somehow prevent them from becoming addicted or dependent • Many studies show that HCP’s may believe their knowledge of drug therapy justifies self-treatment Road to Recovery
  • 7. The Addicted Pharmacist and the Effect of Their Environment University of Findlay College of Pharmacy PRN Survey (N 171—25%) • From Discovery to Recovery • 93% attended Some form of Rehabilitation – Of which 63% Successful on First Attempt – Of which 18% Successful on Second Attempt – Of which 11% Successful on Third Attempt Road to Recovery
  • 8. CDM: Performance Measures Help Guide Care Road to Recovery
  • 9. “Blueprint” Study McLellan et.al., BMJ, Nov. 2008 • 16 American PHPs retrospective longitudinal study • 904 consecutive MDs with SUDs, 647 monitored • 81% never relapsed over five years • 79% licensed and working after five years • 11% revoked • 3.5% retired • 3.5% died • 3% status unknown Road to Recovery
  • 10. Relapse Risk (Washington State PHP) (Domino, et. al. JAMA, Mar 23, 2005) Retrospective Cohort Study • Relapse rate: 25% (74 of 292 cases between 1991- 2001) • Increased relapse risk if:– Concurrent psychiatric disorder (HR 5.79) – Family history of substance use disorder (HR 2.29) – Previous major relapse (HR 1.69) – Combinations of these adds to cumulative risk – Major Opioid/Dual Diagnosis/Family History (HR 13.25) • No increased relapse risk: – Drug of choice • Including major opioid as long as above factors absent – Specialty – Gender Road to Recovery
  • 11. OMA PHP Relapses - 5 Year Program First 100 monitored participants Brewster, Kaufmann et al; BMJ Nov 2008 Road to Recovery
  • 12. LIFE SATISFACTION* BY PROGRAM YEAR - OMA PHP YEAR IN PROGRAM * Mean of 14-items: 4-Very satisfied; 3-Satisfied; 2-Dissatisfied; 1-Very dissatisfied R2 = .813; Regression constant = 3.266; Slope = 0.0498 (p = .037) Road to Recovery
  • 13. PFSP Program Evaluation 2008: Did PFSP make a difference for participants in case coordination? 90% of responding participants reported that the problem that had caused them to access the program had improved (46% responded) • Overall wellness • Job effectiveness • Relationships with others full 76% partial 14% full 71% partial 14% full 71% partial 24% Overall life satisfaction • Beginning of case coordination3.7/10 • Conclusion of last interaction 8.1/10 Road to Recovery
  • 14. Special Issues of Return to Work • PHP/PRNs usually spell out the conditions for a HCP’s return to practice via a contract. • Most Regulator’s specify only that the HCP return to work should be based on her/his ability to practice with “reasonable skill and safety”—leaving judgement up to treatment team Road to Recovery
  • 15. Special Issues of Return to Work • Assessment of her/his: – Acceptance of SUD diagnosis – Understanding of addiction as a chronic disease requiring lifelong attention – Completion of SUD treatment, with support of treatment team to resume work – Documentation of sustained abstinence(UDS). – Treatment and status of Co-occurring Mental Disorders – Judgment and cognition (neuropsychological testing) – HCP’s ability to manage stress and triggers – Support Network including Family support – Estimated risk of Relapse – Motivation to follow an established continuing care plan – Occupational Factors: • Legal/Licensure Requirements Satisfied • Workplace monitor/supervisor identified and accepts responsibilities • Necessary Workplace modification or practice restrictions have been agreed to Road to Recovery
  • 16. Special Issues of Return to Work • Staged Process • May have limited work hours, tasks, time of day, or settings • May face restrictions to access to mood-altering medications • Workplace monitor in contact with PHP/PRN (release for communication in effect at all times) • Settings of practice limited to provide for easier monitoring/better accountability • Accountability System for dispensing/administering addicting drugs to patients – Not being the person in the practice to check a patient’s medications for compliance – Keeping track of prescriptions written for controlled substances – Using double locked systems for addicting substances on premises – Periodic checking of wastage from injectable opioids to assure all vials and their contents are properly accounted for & have not been diverted Road to Recovery
  • 17. Applying Occupational Health Principles • Safety-Sensitive Profession • Workplace education and accommodations are often required • Participate in return to work planning with the participant and the workplace • Fitness for work measured by performance on a range of work tasks from low to higher risk • Scrutiny and accountability in the workplace is necessary • Monitor long-term for Health and Recovery Road to Recovery
  • 18. Relapse: Road to Recovery Dr. Jay Piland MD Palmetto Addiction Recovery Center Pecan Haven Adolescent Addiction Center
  • 21. Relapse: • Definition varies according to source text. • Addiction Medicine-Fourth Edition 2009: • Uses terms Lapse, Relapse, and Recovery. • Some argument over what constitutes a Relapse-but not from PHP programs. Use a higher standard of complete abstinence from mood altering substances. Road to Recovery
  • 22. Lapse • Marlatt defines as the initial episode of use of a substance after a period of abstinence. • Not really recognized for professionals. Road to Recovery
  • 23. Relapse: • “ a discrete phenomenon or a process of behavioral change” • “an unfolding process in which the resumption of substance use is the LAST event in a long series of maladaptive responses to internal or external stressors or stimuli” • “ a continuous process defined by a series of transgressive behaviors” Road to Recovery
  • 27. Behavior Patterns • It’s the behavior stupid. • Mechanism of response to stressors and stimuli—I.E.—LIFE. • Response can be healthy or maladaptive Road to Recovery
  • 28. Recovery • Recovery is defined as a long-term and ongoing process rather than an endpoint. • Specific areas of change during the process of recovery include physical, psychologic, spiritual, behavioral, interpersonal, sociocultural, familial, and financial. • Recovery tasks and areas of clinical focus are contingent on the phase of recovery . Road to Recovery
  • 29. Stages of Relapse: • Used by PHP and RNP programs nationwide. • 3 stages of relapse. • Evidence shows progression over time. • Measurement of severity of relapse but not necessarily indicative of recommended corrective actions from monitoring programs. Road to Recovery
  • 30. Level 1 Relapse • A level 1 relapse consists of missing therapy meetings, support groups, dishonesty, or other behavioral infractions. • Note-no mention of substances. Road to Recovery
  • 31. Level 2 Relapse • A level 2 relapse involves the reuse of drugs or alcohol but outside the context of medical practice. • Not necessarily a person’s drug of choice. Road to Recovery
  • 32. Level 3 Relapse • Involves the use of drugs or alcohol within the context of medical practice. • Main goal of PHP programs is to prevent this occurence. • PHP’s, PRN’s, and RNP’s primary directive: Protect the Public. Road to Recovery
  • 33. Consequences • Different for professionals than the general public because we present a greater danger than just to ourselves. • “Physicians who have difficulty maintaining abstinence should be removed from the workforce until treatment providers….feel that the physician is safe to return to work.” Road to Recovery
  • 34. Consequences 2 • “ The point in time when a physician is safe to practice is best determined by a joint decision of the physician’s treatment provider and the monitoring PHP.” Road to Recovery
  • 35. Determinants of Relapse • Marlatt’s Relapse Taxonomy: • Intrapersonal Determinants – Self Efficacy – Outcome Expectancies – Cravings – Motivation – Coping – Emotional States • Interpersonal Determinants Road to Recovery
  • 36. Intrapersonal Determinants • Self-efficacy: refers to the individuals beliefs in their capabilities to organize and carry out specific courses of action to attain some goal or situation specific task. • This construct is intimately related to the individual’s coping abilities. • The patient’s personal belief in his or her ability to control substance use is a reliable predictor of relapse. Road to Recovery
  • 37. Self-Efficacy • If you believe you can you will. • Confidence in your ability to control your substance use is intimately related with your coping skills. • Coping behaviors should be thoroughly assessed during treatment and appropriately targeted for interventions. Road to Recovery
  • 39. Outcome Expectancy • A factor enhancing the likelihood of relapse is the set of cognitive expectancies that individuals develop regarding the expected outcomes of substance use. • If it feels good do it. Not a good plan. • Treatment should focus to some extent on changing the individual’s outcome expectancies regarding substance use. Road to Recovery
  • 41. Craving • Defined as a cognitive experience focused on the desire to use a substance. • Closely related to outcome expectancies. • Different from behavioral urges. • Treatment should also include an evaluation of cravings and appropriate readjustment based on outcome expectancies. Road to Recovery
  • 43. Motivation • Gorski: The degree to which a person’s behavior differs from their ideal behavior beliefs is the degree of that person’s insanity. • The person’s desire for self improvement and commitment to change is a strong predictor of relapse. • Ambivalence toward change is the enemy of recovery. Road to Recovery
  • 45. Coping • “Based upon cognitive-behavioral model of relapse, the most critical predictor of relapse is the individuals ability to utilize adequate coping strategies in dealing with high-risk situations.” • One of the most effective coping strategies available is mindfulness and meditation. • Foundation of behavioral change. Road to Recovery
  • 48. Emotional States • Studies show a strong link between negative affect and relapse to substance abuse. • It is the cornerstone of effective recovery; affect is a strong determinant of subsequent behavior. • Two things you can control: Attitude and Behavior. They are intimately associated. Road to Recovery
  • 50. Interpersonal Determinants • Functional support or the level of emotional support is highly predictive of long term abstinence and recovery. • Behavioral therapy which incorporates partner support in treatment goals is one of the top three empirically supported treatment methods for alcohol problems. • Al-Anon is born. Road to Recovery
  • 52. Top 10 ways to Prevent Relapse • 1) Help patients understand relapse as a process and event, and learn to identify warning signs. Road to Recovery
  • 53. RP • 2) Help patients identify their high risk situations and develop effective cognitive and behavioral coping. Road to Recovery
  • 54. RP • 3) Help patients enhance their communication skills, interpersonal relationships, and develop a recovery social network. Road to Recovery
  • 55. RP • 4) Help patients reduce, identify, and manage negative emotional states. Road to Recovery
  • 56. RP • 5) Help patients identify and manage cravings and cues that precede cravings. Road to Recovery
  • 57. RP • 6) Help patients identify and challenge cognitive distortions. Road to Recovery
  • 59. RP • 7) Help patients work toward a more balanced lifestyle. Road to Recovery
  • 60. RP • 8) Consider the use of medications in combination with psychosocial treatments. Road to Recovery
  • 61. RP • 9) Facilitate the transition between levels of care for patients completing residential or hospital based inpatient treatment programs, or structured partial hospital or intensive outpatient programs. • PRN’s PHP’s RNP’s CM Road to Recovery
  • 62. RP • 10) Incorporate strategies to improve adherence to treatment and medication. Road to Recovery
  • 63. Susan P. Rx Relapse ? • Susan is a 35 year old Pharmacist who was treated for alcohol SUD at the age of 24. After treatment she enrolled in the PRN monitoring and signed a 5 year monitoring contract. • After the completion of her five year contract at the age of 29 she had been very engaged in her peer support recovery program (AA, Caduceus, Continuing Care, and UDS monitoring) but stopped going about six months before the end of her contract. • Three months prior to completion of her contract, Susan discovered she was pregnant—she had noticed a significant mood change(depression) and an increase in her anxiety level due to difficulty with her supervisor at work (Hospital Pharmacy). She also was increasingly anxious due to her infidelities which occurred with another coworker who was a 22 year old pharmacy student—which she ended at 8 months into her pregnancy—after being involved with him for several months. Road to Recovery
  • 64. Susan P Rx Relapse ? • Is Susan P. in Relapse? • Would she benefit from being in a social recovery Network? • How could she be better managing her “negative emotional state”? • What emotions are driving that “state”? Road to Recovery
  • 65. Susan P Rx Relapse? • She had a child (son) who was born about six months after completing her monitoring contract(out of meetings for about 1 year. She did have to undergo a C-section and the birth was complicated with some fetal distress prior to delivery—yet no anomalies were noted in the infant. Susan received a Rx for Percocet 10mg after the C-section and took three refills. (when taking the Percocet—she began to think about a repeated dose within 1 hour of last dose and could not get it off her mind) • Susan returned to work after only 8 weeks at home after the C- section. She had stopped having contact with her sponsor as she was no longing attending AA meetings (not enough time). Also her sponsor had advised her to end the previous relationship after Susan had only one sexual encounter with him at age 33—she did not follow the suggestions—the relationship continued for several months. She had been working with a girl in early recovery but stopped working with her after stopping the meetings. Road to Recovery
  • 66. Susan P. Rx Relapse • Is Susan in Relapse? • What Level? • What did she not do with her pregnancy/delivery? • What could Susan have done with Cravings? Road to Recovery
  • 67. Susan P Rx Relapse ? • Susan returned to her habit of smoking cigarettes (she had stopped at age 24) only two weeks after her son was born. Susan also began to experience recurring episodes of dysphoria within that same time frame, she also experienced recurring “flash-backs” of early childhood sexual trauma she experienced at the age of 8 by an “uncle”. She would have recurrent thoughts of being worthless and not being able to do anything right—she began to think that her tendency to “gamble” was the reason for sexual trauma “flash-backs”. • She was responsible for filling the Pyxis machines with all of the narcotics when she returned to work from maternity leave—so she progressively increased her use up to 25 Percocet tablets daily. She took “50 Percocet capsules” in a “suicide attempt” when her supervisor began to perform internal Pyxis pharmacy audits. She now presents for an addiction assessment after getting out of the acute care hospital. • Road to Recovery
  • 68. Susan P Rx Relapse? • 15. Does Cigarette Smoking increase her risk of relapse? • 16. What should she do about “flash-backs”? • 17. What should she do about cognitive distortions? • 18. Should she be on MAT? Vivitrol? • 19. What is most appropriate next step? Road to Recovery
  • 69. Susan P. Rx Relapse? True/False? 21. Relapse Prevention plans should always be started at the middle/end of treatment. 22. Performing a relapse autopsy is always useful. 23. Most HCP’s who relapse, always loose their license and ability to practice their profession. 24. Many HCP’s who have an early relapse, often are able to achieve and improved footing/foundation of a recovery program. 25. IDAA. Look us up www.ida.org Road to Recovery
  • 70. Relapse: Road to Recovery Dr. Jay Piland MD Palmetto Addiction Recovery Center Pecan Haven Adolescent Addiction Center